PF-06305591 blocks sodium channels, affecting the action potential propagation in neurons and muscle cells, crucial for neurological and muscular function. It targets Nav1.8.
Molecular Weight
274.36
Molecular Formula
C15H22N4O
Targets
Nav1.8: 15 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
PF-06305591 is a sodium channel inhibitor researched for its potential analgesic effects and application in pain management therapies.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
